CATHERINE J MACKEY
CIK 1645330 · last filed 2026-06-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
8
Total Filings
34
Lifetime Open-Market Net
-$37.2K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IDYA | Director | — | $37.93 | — | $0 | 5 | 2026-06-18 |
| VYGR | Director | — | $3.30 | — | $0 | 5 | 2026-06-11 |
| Avid Bioservices, Inc. (CDMO) Delisted | Director | 43,379 | $12.49 | $541.8K | $0 | 4 | 2024-12-17 |
| Trillium Therapeutics Inc. (TRIL) Delisted | Director | — | $19.86 | — | $0 | 1 | 2021-07-02 |
| GW PHARMACEUTICALS PLC (GWPH) Delisted | Director | 10,536 | $218.96 | $2.31M | -$37.2K | 8 | 2021-03-02 |
| Avid Bioservices, Inc. (CDMOP) Delisted | Director | — | $25.06 | — | $0 | 3 | 2020-12-16 |
| Poseida Therapeutics, Inc. (PSTX) Delisted | Director | — | $9.50 | — | $0 | 1 | 2020-07-13 |
| SEQUENOM INC (SQNM) Delisted | Director | 0 | — | — | $0 | 4 | 2016-09-07 |
Recent Filings · Page 2 of 4
34 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-06-07 | VYGR | Grant (A) | — | $0 | EDGAR |
| 2022-12-16 | Avid Bioservices, Inc. (CDMO) Delisted | Mixed | +4,632 | $0 | EDGAR |
| 2022-08-16 | VYGR | Grant (A) | — | $0 | EDGAR |
| 2022-04-06 | IDYA | Grant (A) | — | $0 | EDGAR |
| 2021-12-16 | Avid Bioservices, Inc. (CDMO) Delisted | Mixed | +2,379 | $0 | EDGAR |
| 2021-11-19 | — | Disp (D) | — | $0 | |
| 2021-07-02 | Trillium Therapeutics Inc. (TRIL) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-05-07 | — | Disp (D) | −10,536 | $0 | |
| 2021-03-02 | GW PHARMACEUTICALS PLC (GWPH) Delisted | Mixed | +1,884 | -$22.5K | EDGAR |
| 2021-02-24 | GW PHARMACEUTICALS PLC (GWPH) Delisted | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.